Anna López‐Ferrer

1.4k total citations
55 papers, 935 citations indexed

About

Anna López‐Ferrer is a scholar working on Immunology, Rheumatology and Dermatology. According to data from OpenAlex, Anna López‐Ferrer has authored 55 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 21 papers in Rheumatology and 15 papers in Dermatology. Recurrent topics in Anna López‐Ferrer's work include Psoriasis: Treatment and Pathogenesis (38 papers), Spondyloarthritis Studies and Treatments (20 papers) and Dermatology and Skin Diseases (12 papers). Anna López‐Ferrer is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (38 papers), Spondyloarthritis Studies and Treatments (20 papers) and Dermatology and Skin Diseases (12 papers). Anna López‐Ferrer collaborates with scholars based in Spain, Russia and Portugal. Anna López‐Ferrer's co-authors include L. Puig, Eva Vilarrasa, Carme de Bolós, Carlos Barranco, Marta Garrido, Ignasi Gich, A. Alomar, A. Laíz, D. Vidal and J.M. Carrascosa and has published in prestigious journals such as Gut, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Anna López‐Ferrer

54 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna López‐Ferrer Spain 19 630 303 260 179 107 55 935
Tomas Norman Dam Denmark 14 491 0.8× 180 0.6× 148 0.6× 69 0.4× 64 0.6× 25 710
James Proulx United States 4 551 0.9× 295 1.0× 53 0.2× 275 1.5× 84 0.8× 4 827
M. Buonanno United States 7 479 0.8× 282 0.9× 49 0.2× 227 1.3× 87 0.8× 7 749
Joanna Ashton‐Chess France 18 540 0.9× 28 0.1× 148 0.6× 112 0.6× 33 0.3× 34 1.3k
Peter Noertersheuser United States 10 181 0.3× 45 0.1× 141 0.5× 165 0.9× 50 0.5× 22 626
K A Wright United Kingdom 16 189 0.3× 33 0.1× 255 1.0× 84 0.5× 13 0.1× 25 864
Lori Ann Cox United States 11 145 0.2× 199 0.7× 93 0.4× 123 0.7× 15 0.1× 17 650
Naresh Punwani United States 12 224 0.4× 124 0.4× 178 0.7× 230 1.3× 33 0.3× 17 803
Sang Joon Lee South Korea 19 1.7k 2.7× 21 0.1× 88 0.3× 473 2.6× 23 0.2× 40 2.2k
Laure Favier France 16 193 0.3× 25 0.1× 328 1.3× 26 0.1× 94 0.9× 61 1.0k

Countries citing papers authored by Anna López‐Ferrer

Since Specialization
Citations

This map shows the geographic impact of Anna López‐Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna López‐Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna López‐Ferrer more than expected).

Fields of papers citing papers by Anna López‐Ferrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna López‐Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna López‐Ferrer. The network helps show where Anna López‐Ferrer may publish in the future.

Co-authorship network of co-authors of Anna López‐Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Anna López‐Ferrer. A scholar is included among the top collaborators of Anna López‐Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna López‐Ferrer. Anna López‐Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cantó, Elisabet, Marta Prado, Eva Vilarrasa, et al.. (2025). Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis. International Journal of Molecular Sciences. 26(17). 8118–8118.
2.
3.
López‐Ferrer, Anna, et al.. (2023). Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives. Patient Preference and Adherence. Volume 17. 1541–1549. 2 indexed citations
4.
López‐Ferrer, Anna, et al.. (2022). A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence. International Journal of Clinical Pharmacy. 44(3). 725–730. 8 indexed citations
5.
Iznardo, Helena, Eva Vilarrasa, Anna López‐Ferrer, & L. Puig. (2021). Real‐world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis. British Journal of Dermatology. 185(3). 660–662. 17 indexed citations
6.
Alcázar, E. del, Anna López‐Ferrer, Álvaro Martínez‐Doménech, et al.. (2021). Effectiveness and safety of guselkumab for the treatment of psoriasis in real‐world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group. Dermatologic Therapy. 35(2). e15231–e15231. 18 indexed citations
7.
López‐Ferrer, Anna, et al.. (2017). Unidades psoriasis-artritis: 3 años después. Actas Dermo-Sifiliográficas. 109(2). 101–103. 1 indexed citations
8.
Vilarrasa, Eva, et al.. (2016). ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice. Journal of the American Academy of Dermatology. 74(6). 1066–1072. 53 indexed citations
9.
10.
López‐Ferrer, Anna, et al.. (2014). Vismodegib: A Review. Actas Dermo-Sifiliográficas. 105(8). 744–751. 2 indexed citations
11.
López‐Ferrer, Anna, et al.. (2014). Actualización en artritis psoriásica. Actas Dermo-Sifiliográficas. 105(10). 913–922. 8 indexed citations
12.
Puig, L., Anna López‐Ferrer, & A. Laíz. (2014). Etanercept en el tratamiento de la artritis psoriásica. Actas Dermo-Sifiliográficas. 106(4). 252–259. 4 indexed citations
13.
López‐Ferrer, Anna, et al.. (2013). Vismodegib: revisión. Actas Dermo-Sifiliográficas. 105(8). 744–751. 12 indexed citations
14.
15.
Mejías‐Luque, Raquel, Anna López‐Ferrer, Marta Garrido, Àngels Fabra, & Carme de Bolós. (2007). Changes in the invasive and metastatic capacities of HT‐29/M3 cells induced by the expression of fucosyltransferase 1. Cancer Science. 98(7). 1000–1005. 28 indexed citations
16.
López‐Ferrer, Anna, Carlos Barranco, & Carme de Bolós. (2002). Differences in the O-Glycosylation Patterns Between Lung Squamous Cell Carcinoma and Adenocarcinoma. American Journal of Clinical Pathology. 118(5). 749–755. 29 indexed citations
17.
López‐Ferrer, Anna, Francesc Alameda, Carlos Barranco, Marta Garrido, & Carme de Bolós. (2001). MUC4 expression is increased in dysplastic cervical disorders. Human Pathology. 32(11). 1197–1202. 29 indexed citations
18.
López‐Ferrer, Anna, Víctor Curull, Carlos Barranco, et al.. (2001). Mucins as Differentiation Markers in Bronchial Epithelium: Squamous Cell Carcinoma and Adenocarcinoma Display Similar Expression Patterns. American Journal of Respiratory Cell and Molecular Biology. 24(1). 22–29. 75 indexed citations
19.
20.
Carvalho, Filipa, Leonor David, Jean‐Pierre Aubert, et al.. (1999). Mucins and mucin-associated carbohydrate antigens expression in gastric carcinoma cell lines. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 435(5). 479–485. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomas Norman Dam Breakdown of academic impact, for papers by James Proulx Breakdown of academic impact, for papers by M. Buonanno Breakdown of academic impact, for papers by Joanna Ashton‐Chess Breakdown of academic impact, for papers by Peter Noertersheuser Breakdown of academic impact, for papers by K A Wright Breakdown of academic impact, for papers by Lori Ann Cox Breakdown of academic impact, for papers by Naresh Punwani Breakdown of academic impact, for papers by Sang Joon Lee Breakdown of academic impact, for papers by Laure Favier
Rankless by CCL
2026